Periodontitis Completed Phase 2 Trials for Trafermin (DB06244)

Also known as: PERIODONTITIS / Chronic pericoronitis

IndicationStatusPhase
DBCOND0010286 (Periodontitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00199290A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in JapanTreatment
NCT00514657Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2Treatment